Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Sarcoidosis affecting the tissues of the heart.
Biomarker and diagnostic research for cardiac sarcoidosis has been reported in the published literature.
18 clinical trials registered, 14 recruiting. Interventions under study include other interventions, drug therapy, and biologic therapy. Pipeline includes 1 PHASE3, 4 PHASE2, 3 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT05499637](https://clinicaltrials.gov/study/NCT05499637) |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 11:55 AM UTC
[68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation |
PHASE2 |
John O. Prior |
RECRUITING |
[NCT01477359](https://clinicaltrials.gov/study/NCT01477359) | Cardiac Sarcoidosis Multi-Center Prospective Cohort | — | Ottawa Heart Institute Research Corporation | RECRUITING |
[NCT07336394](https://clinicaltrials.gov/study/NCT07336394) | Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques | — | Chinese Academy of Medical Sciences, Fuwai Hospital | RECRUITING |
[NCT03858777](https://clinicaltrials.gov/study/NCT03858777) | Cell Free DNA in Cardiac Sarcoidosis | NA | Nabeel Hamzeh | RECRUITING |
[NCT04737317](https://clinicaltrials.gov/study/NCT04737317) | Diagnostic Criteria in Cardiac Sarcoidosis | — | Heart Center Leipzig - University Hospital | RECRUITING |
244 publications have been identified in PubMed for cardiac sarcoidosis. Kisho has analyzed 144 by research type. Research spans Review / Meta-Analysis (49%), Epidemiology / Natural History (12%), and Other (11%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 71 | 49% |
Disease patterns and progression | 17 | 12% |
Other research | 16 | 11% |
Testing and diagnosis research | 15 | 10% |
Patient case studies | 13 | 9% |
Clinical study results | 7 | 5% |
Laboratory research | 5 | 3% |
Nagai T (2026). [PMID: 41882902](https://pubmed.ncbi.nlm.nih.gov/41882902/). *Intern Med*. [Review / Meta-Analysis]
Aslam A (2026). [PMID: 41813098](https://pubmed.ncbi.nlm.nih.gov/41813098/). *Heart*. [Review / Meta-Analysis]
Wagle AA (2026). [PMID: 42233912](https://pubmed.ncbi.nlm.nih.gov/42233912/). *JACC Case Rep*. [Case Report / Case Series]
Sovani B (2026). [PMID: 42225514](https://pubmed.ncbi.nlm.nih.gov/42225514/). *Semin Nucl Med*. [Review / Meta-Analysis]
Vishnu S (2026). [PMID: 42240508](https://pubmed.ncbi.nlm.nih.gov/42240508/). *Natl Med J India*. [Epidemiology / Natural History]
Peretto G (2026). [PMID: 41622435](https://pubmed.ncbi.nlm.nih.gov/41622435/). *Immunol Rev*. [Review / Meta-Analysis]
Tana C (2026). [PMID: 42077039](https://pubmed.ncbi.nlm.nih.gov/42077039/). *Expert Rev Cardiovasc Ther*. [Other]
Neyazi M (2026). [PMID: 42206386](https://pubmed.ncbi.nlm.nih.gov/42206386/). *Circulation*. [Basic Science / Preclinical]
Hena KM (2026). [PMID: 40885536](https://pubmed.ncbi.nlm.nih.gov/40885536/). *Chest*. [Epidemiology / Natural History]
Tana C (2026). [PMID: 41474488](https://pubmed.ncbi.nlm.nih.gov/41474488/). *Am J Cardiovasc Drugs*. [Review / Meta-Analysis]
AI-curated news mentioning cardiac sarcoidosis
Updated Mar 11, 2026
Recent research highlights advancements in cardiac imaging techniques for diagnosing and managing cardiac sarcoidosis. The study emphasizes the need for improved imaging modalities to enhance patient outcomes.
A case report explores the association between cardiac sarcoidosis and coronary slow flow, providing insights into this complex relationship. This study contributes to the understanding of cardiac manifestations in sarcoidosis patients.
A recent study highlights significant diagnostic delays and phenotypic variations in cardiac sarcoidosis, emphasizing the need for improved diagnostic protocols. The findings could inform future research and clinical practices in managing this rare condition.